menu
    • menu

    Company profile for Zhejiang Hisun Chemical Co., Ltd.

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-05-19

    Virtual Booth

    Contact Supplier

    Chirogate is a professional Prostaglandin manufacturer.

    Virtual Booth

    Contact Supplier

    Temad- We think of world-class quality.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Zhejiang Hisun Chemical Co., Ltd (hereafter called as ”Hisun Chemical), founded in 1998, is a state-holding enterprise invested by State Development & Investment Corporation(SDIC), Zhejiang Hisun Group and ZMC Co., Ltd. The company now covers an area of 312,000 square meters and 35% of its staff members are technicians. With its total assets of nearly USD 60 million, Hisun Chemical has created a niche in agrochemical field t...
    Zhejiang Hisun Chemical Co., Ltd (hereafter called as ”Hisun Chemical), founded in 1998, is a state-holding enterprise invested by State Development & Investment Corporation(SDIC), Zhejiang Hisun Group and ZMC Co., Ltd. The company now covers an area of 312,000 square meters and 35% of its staff members are technicians. With its total assets of nearly USD 60 million, Hisun Chemical has created a niche in agrochemical field through its sustainable researching, marketing efforts and strong distribution network. The company, with its headquarter located in Taizhou, Zhejiang, now has two wholly-owned subsidiary companies , two Sino-foreign joint ventures and one Provincial Hi-tech R&D Centre. Since it was established, Hisun Chemical has already passed ISO9000 & ISO14000 and gained lots of honors like “First AA-level Credit Enterprise of China Pesticide Industry” and “National Hi-tech Enterprise”, etc. Its product, Abamectin has also gained such awards as ”First Prize of S&T Advance Award of China Chemical Industry”, “Major Achievements in National Technologies R&D Program of the 8th Five-year plan of China” and “ Outstanding Project Award in National Technology Innovation Program of the 8th Five-year of China”. Meanwhile, Hisun Chemical has also undertaken the project of Emamectin Benzoate in National Key Technologies R&D program of the 9th Five-year plan of China. And Ascomycin, a kind of its biofungicides, has been listed in “National S&T Pillar Program of Technical Material Development in the 11th Five-year plan of China.” Based on full implement of EHS system and high quality product, Hisun Chemical has been one of the suppliers to many multinational companies, like Bayer, Syngenta, Boehringer Ingelheim and Cheminova, establishing long term business relationship with them. Hisun Chemical exports 85% of its products, ranging from Insecticides, Herbicides to Fungicides, directly to more than 50 countries over the world. Among those products, its patented products such as Oxine copper 33.5% SC & Flazasulfuron have obtained exclusive registration in China. Hisun Chemical adheres to “For Shareholders, For Staff, For Community” as its management purpose, “Honesty, Innovation, Collaboration& Diligence” as its core values, and “Broad Mind& Integrity” as its spirit. With advanced technology, and R&D, Hisun Chemical will strive to become a representative of Agrochemical, Pharmaceutical &Animal Health Field in the 21st century. Our Group-ZHEJIANG HISUN GROUP The original name of Hisun is HaiMen Pharmaceutical Company founded in 1956 and changed her name at 1997 to Zhejiang Hisun Group. Hisun is located in Taizhou, which is a scenic and coastal city at East Sea in China and is part of the southern tip of Shanghai Economic Zone. It contains 100 hectare area and there are more than 3000 employees. Hisun is ranked in the top 520 key enterprises in China, total asset of Hisun has reached RMB 1.6 billion, there is a national R&D center in Hisun and more than 30% of its staff are technician. Hisun has developed into the largest antibiotic and antineoplastic manufacturer and become a reputed one of main chemical production bases in China. There are three main subsidiary companies under Hisun Group which are Hisun pharmaceutical has been listed in SSE, Hisun Chemical and Hisun thermoelectricity. T products of Hisun have been approved and certified by FDA of U.S.A. meanwhile Hisun have got the approvals of ISO9001, ISO9002 and ISO14000. Hisun exports 80% of its products to approximately 100 countries all over the world, the products performance has been approved by domestic and international consumers.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Zhejiang Hisun Chemical Co., Ltd.China Flag
    Country
    Country
    China
    Address
    Address
    No.97 Waisha Road, Jiaojiang District, Taizhou, Zhejiang 318000
    Telephone
    Telephone
    +86 576 88827793
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.hisunchem.com/eabout.asp
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CPhI North America

    Not Confirmed

    envelop Contact Supplier

    CPhI North America

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    Alchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets

    micAlchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets

    With increasing flavour bans in key markets, vaping brands are facing significant challenges in providing satisfying alternatives to vapers and smokers looking to transition. Recognising this need, Alchem NicSelect™ is making a bold move by offering its key customers royalty-free and unrestricted geographical access to its revolutionary T-MAX™ technology.“At Alchem NicSelect™, we understand the urgency for vaping brands to adapt to new regulations without compromising on satisfaction. By offering royalty-free access to T-MAX™ technology, we empower our customers to provide the closest cigarette-like experience possible, even in markets with strict flavour restrictions,” said Riccardo Santambrogio, Europe Sales Manager.HIGHLIGHTS// offering royalty-free access to T-MAX™ technology/ unrestricted geographical access/ closest cigarette-like experience Addressing the biggest barrier: Nicotine satisfactionOne of the primary reasons many vapers are dissatisfied and smokers struggle to switch to vaping is that traditional nicotine solutions fail to replicate the rapid satisfaction provided by cigarettes. Nicotine replacement therapies (NRTs) and even conventional vaping products often lack the immediate nicotine hit, throat feel, and overall experience that smokers are accustomed to. T-MAX™ solves this problem by engineering a nicotine experience that closely mimics cigarette consumption without relying on flavours.T-MAX™ provides a unique 3-in-1 approach:1. The Speed of a Cigarette – Rapid nicotine delivery and rush within seconds for immediate satisfaction.2. The Power of Nicotine Salts – A stronger perceived nicotine effect without exceeding legal limits (20 mg/ml nicotine limit under the European Tobacco Products Directive). With T-MAX™, 8 mg/ml feels like 20 mg/ml, and 14 mg/ml feels like 40 mg/ml.3. The Throat Hit of Freebase Nicotine – Especially in a flavour-free formulation, the combined ingredients in T-MAX™ deliver an even more satisfying throat feel than expected from nicotine base, much closer to and more familiar with a cigarette throat feel that habitual smokers recognise.HIGHLIGHTS// unique 3-in-1 approach/ rush within seconds/ stronger perceived nicotine effect without exceeding legal limits/ more satisfying throat feel that habitual smokers recogniseNo flavour, but not less satisfyingWhile flavours have traditionally played a role in vaping adoption, market realities are shifting. With flavour bans spreading across regions, brands need solutions that deliver satisfaction without relying on taste. Consumer research has shown that T-MAX™ performs exceptionally well even without added flavours. Since most cigarette smokers do not smoke for the tobacco flavour but rather for the nicotine hit and habitual experience, T-MAX™ provides a viable alternative that aligns with new regulatory landscapes.HIGHLIGHTS// flavour bans spreading across regions/ T-MAX™ performs exceptionally well even without added flavoursEmpowering vape brands with free access to T-MAX™By granting customers royalty-free access to the T-MAX™ technology, Alchem NicSelect™ is removing barriers for vaping brands and original equipment manufacturers (OEMs) looking to adapt to regulatory changes. This open-access approach ensures that manufacturers can integrate T-MAX™ into their product lines without additional costs, allowing them to offer superior nicotine satisfaction in markets where flavours are no longer an option.HIGHLIGHTS// removing barriers for vaping brands and OEMs looking to adapt/ manufacturers can integrate T-MAX™ into product lines without additional costsThe future of vaping in restricted marketsWith T-MAX™, the vaping industry has a powerful tool to retain customers and convert smokers who have struggled with traditional vaping products. By delivering the key elements of cigarette satisfaction — without combustion or flavours — T-MAX™ is set to redefine what a satisfying vape experience means in a post-flavour-ban world.“Our commitment to innovation and accessibility means we are providing our customers with the solutions they need to navigate an evolving regulatory landscape. T-MAX™ allows brands to offer a highly satisfying experience that mimics smoking without relying on flavours. The message is clear: no flavour, but not less satisfying”, added Santambrogio.HIGHLIGHTS// powerful tool to retain customers and convert smokers/ delivering the key elements of cigarette satisfaction without combustion or flavours/ no flavour, but not less satisfying

    Impressions: 274

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets

    Radio Compass
    06 May 2025
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    ReelPharmaConnecting People, Mentalities & MarketsConnecting People, Mentalities & Markets

    Connecting People, Mentalities & Markets
    Connecting People, Mentalities & Markets

    reelConnecting People, Mentalities & Markets

    This PharmaReel highlights Transo-Pharm USA’s offerings of premium Phyto Cannabidiol (CBD) and Phyto Cannabigerol (CBG) isolates from its cGMP-certified facility inspected by the FDA and ANVISA. The company has an expanded reach across the US and EU.

    Impressions: 332

    read-more

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    DMF filings surge 44% in Q1 2025; India tops list with 51% rise in year-on-year submissions

    DMF filings surge 44% in Q1 2025; India tops list with 51% rise in year-on-year submissions

    The first quarter (Q1) of 2025 witnessed an impressive surge in Drug Master File (DMF) submissions to the US Food and Drug Administration (FDA), signaling a robust expansion in pharmaceutical development activities, the looming threat of tariffs notwithstanding.A total of 339 Type II DMFs were submitted during this period, as opposed to 235 submissions in Q1 2024, marking an exceptional increase of 44.26 percent. PharmaCompass’ data suggests that this is a record high for any first quarter.Overall, 440 DMFs were submitted across all categories (Types II, III, IV, and V) during Q1 2025, compared to 353 in the same period last year — representing a 24.65 percent increase.India and China continued to dominate the DMF landscape. India led with 162 submissions in Q1 2025, posting a remarkable 51.4 percent increase over 107 submissions recorded in Q1 2024. China followed with 135 submissions, representing a 33.66 percent increase over the 101 filings in Q1 2024.Taiwan sprung a surprise as a distant third. It made 12 DMF submissions in Q1 2025, as opposed to just one in Q1 2024. Western countries like the US, Spain, Germany, and Italy have maintained relatively stable or declining submission rates. Only the Netherlands showed significant growth with four DMF submissions in Q1 2025, up from zero in Q1 2024. View FDA DMF Filings in Q1 2025 (Power BI Dashboard, Free Excel Available)Indian giants MSN, Aurobindo, Cipla, Dr Reddy’s lead record-breaking DMF surgeIndia lived up to its “pharmacy of the world” reputation with the highest DMF submissions. In fact, seven of the top eight companies in the DMF tally were headquartered in India. MSN Group, emerged as the unequivocal leader with 23 submissions in Q1 2025, as against 15 in Q1 2024. Aurobindo Pharma increased its DMF activity from seven submissions in Q1 2024 to 12 in Q1 2025. Alivus Life Sciences, formerly known as Glenmark, made a dramatic leap with eight submissions in Q1 2025, quadrupling its previous year’s count of just two. Cipla more than doubled its DMF submissions — from three in Q1 2024 to eight in Q1 2025.Dr. Reddy’s Laboratories, one of India’s largest generic drugmakers, filed seven DMF submissions. The company’s Q1 2025 DMF portfolio includes high-value molecules like deucravacitinib, finerenone, enzalutamide, niraparib tosylate monohydrate, tucatinib, and tizanidine hydrochloride.Dr. Reddy’s has also indicated that they are open to manufacturing in the US. Meanwhile, Hetero Drugs filed seven submissions while Lee Pharma recorded six in Q1 2025.Chinese manufacturer Jiangsu East-Mab Biomedical Technology also established a significant presence with six DMFs. View FDA DMF Filings in Q1 2025 (Power BI Dashboard, Free Excel Available) Semaglutide, finerenone see most DMF submissions; first-time filings surge 64%Semaglutide and finerenone emerged as the most documented molecules in Q1 2025, each garnering nine DMF submissions. Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist that has revolutionized diabetes management and weight loss treatment, continues to attract significant manufacturer interest. Similarly, finerenone, a non-steroidal drug used in treating chronic kidney disease in type 2 diabetes patients, has garnered attention from manufacturers.Carfilzomib, used in multiple myeloma treatment, secured the third position with five DMF submissions. Deucravacitinib, a novel drug approved for moderate to severe plaque psoriasis, followed with four DMF submissions.There were several molecules with three DMF submissions each. Among them were tapinarof, a novel drug for psoriasis, and tirzepatide, a GLP-1/GIP receptor agonist that has shown remarkable efficacy in diabetes and weight management. During the quarter, 23 molecules received their inaugural DMF submissions. This number has risen by 64 percent since Q1 2024, when only 14 drugs saw their first DMF filings.In Q1 2025, these 23 first-time molecules collectively garnered 30 DMF submissions, with deucravacitinib emerging as the clear leader. Indian companies Dr. Reddy’s Laboratories and Cipla filed DMFs for this plaque psoriasis treatment as did Spain’s Curia and PMC Global.The Q1 2025 roster of first-time DMF filings include retatrutide (another GLP-1 receptor agonist), sotagliflozin, setmelanotide acetate, daridorexant, nusinersen, zavegepant, belzutifan, elacestrant dihydrochloride, selumetinib sulfate, sotorasib, atogepant, omadacycline tosylate, osilodrostat phosphate, ensifentrine, landiolol hydrochloride, maralixibat chloride, maribavir, methyl olivetolate, diazoxide choline, sparsentan, thinnertide, and vismodegib. View FDA DMF Filings in Q1 2025 (Power BI Dashboard, Free Excel Available) Our viewGiven Trump’s rhetoric around tariffs on imported drugs, the record-breaking DMF submissions in Q1 2025 sent out a strong message that the global pharmaceutical industry is willing to take on the complex geopolitical situation with resilience and strategic foresight.On a different note, the rise in DMF filings also indicate increased workload for the FDA staff, as also more inspections by the agency. It seems like more ‘laid off’ FDA employees will be asked to return to work in the coming days.
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 519

    https://www.pharmacompass.com/radio-compass-blog/dmf-filings-surge-44-in-q1-2025-india-tops-list-with-51-rise-in-year-on-year-submissions

    #PharmaFlow by PHARMACOMPASS
    15 May 2025
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    China's Zhejiang Hisun picks up new U.S. deal despite FDA troubles
    China's Zhejiang Hisun picks up new U.S. deal despite FDA troubles

    11 Aug 2016

    // Eric Palmer FIERCE PHARMA

    http://www.fiercepharma.com/manufacturing/china-s-troubled-zhejiang-hisun-keeps-picks-up-new-u-s-business

    Eric Palmer FIERCE PHARMA
    11 Aug 2016
    Share Share

    ABOUT THIS PAGE

    Contact Zhejiang Hisun Chemical Co., Ltd. and get a quotation

    Zhejiang Hisun Chemical Co., Ltd. is a supplier offers 74 products (APIs, Excipients or Intermediates).

    Find a price of 31139-87-4 bulk with JDMF offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of 4-Biphenylacetic Acid bulk with JDMF offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Biotin bulk with JDMF offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Bisbentiamine bulk with JDMF offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Candesartan Cilexetil bulk with JDMF offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Escitalopram Oxalate bulk with JDMF offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Polaprezinc bulk with JDMF offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Procainamide Hydrochloride bulk with JDMF offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Acarbose bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Ademetionine 1,4-Butanedisulfonate bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Ademetionine Disulfate Tosylate bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Adenosine bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Anastrozole bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Apixaban bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Apremilast bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Aripiprazole bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Bedaquiline bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Bicalutamide bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Bleomycin Sulphate bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Cladribine bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Cyclophosphamide bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Cytarabine bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Dactinomycin bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Daptomycin bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Daunorubicin HCl bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Donepezil bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Doxorubicin Hydrochloride bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Eltrombopag bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Emodepside bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Epirubicin Hydrochloride bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Eprinomectin bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Everolimus bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Fipronil bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Fludarabine Phosphate bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Fluralaner bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Fluvastatin Sodium bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Glucosamine Sulfate Sodium Chloride bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Glutathione bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Idarubicin Hydrochloride bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Imidacloprid bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Imipenem + Cilastatin bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Immunomycin bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Isepamicin Sulfate bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Ivermectin bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Letrozole bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Linezolid bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Lovastatin bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Lurasidone Hydrochloride bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Meropenem bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Mesna bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Methoprene bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Micafungin bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Milbemycin Oxime bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Minocycline Hydrochloride bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Mitomycin bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Moxidectin bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Mycophenolate Mofetil bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Mycophenolic Acid bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Orlistat bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Oseltamivir Phosphate bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Pirarubicin HCl bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Pravastatin bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Praziquantel bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Pyrroloquinoline Quinone Disodium bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Rifamycin bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Selamectin bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Simvastatin bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Sirolimus bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Tacrolimus bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Tazobactam Sodium bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Teicoplanin bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Ticagrelor bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Tigecycline bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Find a price of Tulathromycin bulk offered by Zhejiang Hisun Chemical Co., Ltd.

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search